Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of the Impact of Clinicogenetic Risk-Stratified Management on Outcomes of Acute Myeloid Leukemia in Older Patients

NCT03226418 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT03226418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of the Impact of Clinicogenetic Risk-Stratified Management on Outcomes of Acute Myeloid Leukemia in Older Patients
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2017
Completion date
October 1, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute myeloid leukemia, secondary acute myeloid leukemia, therapy-related acute myeloid leukemia